Americans with a chronic disease could soon have better access to affordable treatment if a bipartisan bill just passed by the U.S. House makes it through ...
The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...
Chronic Disease Flexible Coverage Act has passed the House of Representatives and will now go to the Senate. The bipar ...
23h
The National on MSNRising demand for Ventolin inhalers in the UAE causes medication shortageAsthma sufferers in the UAE who rely on Ventolin to relieve symptoms are struggling to refill their medication, with many ...
The bustling capital of Bangladesh now ranks among the most polluted cities on Earth — an alarming reality for its more than 20 million residents.
The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...
A program that supplies schools with stock inhalers was well received by school health personnel/nurses in Illinois, according to two posters presented here.Both posters were presented at the 2025 ...
2d
Hosted on MSNMedical Report: Are asthma inhalers bad for the environment?Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW ...
Jan. 15, 2025 — Researchers have made an important discovery in the field of asthma research, identifying a new population of immune cells that may play a crucial role in the severity of asthma ...
In Chicago public schools that adopted a stock inhaler program, more students who used a stock inhaler for asthma symptoms ...
Despite having the power to set the list price for their medications, pharmaceutical companies are driven by profit and ...
Learn what happens inside the body during an asthma attack and why treatments help prevent or reverse the effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results